Analyst Ratings for Bristol-Myers Squibb Co. (BMY)

Updated: 2017-07-28

Bristol-Myers Squibb Co. (NYSE:BMY) was awarded an average rating of Overweight from investment analysts following the stock. Last month, BMY received an average rating of Overweight.

24 analysts issued ratings on the stock, where 10 gave BMY a buy rating, 1 gave an overweight rating, 10 issued a hold rating, 1 issued an underweight rating, and 2 gave a sell rating. Compared to three months ago, there has been an decrease of 1 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 1.

A number of analysts gave price targets for BMY. The maximum price target given was 68, implying potential capital gains of 25.37 percent. The lowest price target was 40, implying potential capital losses of -26.25 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0.68 percent. The average change in earnings estimates over the last 90 days is 4.27 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0.34 percent. If we look at the last 90 days instead, we find a net average change of 3.53 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. 3 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 4 analysts that decreased their estimates. During this time, 4 analysts made positive revisions in their estimates for this fiscal year's earnings, while 3 analysts made negative revisions to their fiscal year's estimates.

Analysts estimate earnings of BMY to grow at a rate of 3.52 percent. People on Wall Street often look at a company's PEG ratio. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. PEG ratios below 1 are often considered desirable, even though it may be more relevant to compare the ratio to that of a firm's competitors. BMY has a PEG ratio of 5.6.

In the last 52-weeks, BMY has achieved a high of 76.48 and a low of 46.01. The current market price is above the trailing year's low by 17.89 percent, and below the high by 29.08 percent. BMY has a price/earnings ratio of 19.72. Investors typically compare the P/E ratio to a company's peers in the industry. The BMY value stock report compares BMY to some of its peers using value stock charts. The market cap of BMY is $92.22 billion. BMY will post this quarters earnings in days, on 0000-00-00.